Text Size
15 studies found for:    agomelatine

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder
Interventions: Drug: Agomelatine;   Drug: paroxetine;   Drug: placebo
2 Completed Agomelatine in Depressed Patients With Fibromyalgia
Conditions: Major Depression;   Fibromyalgia
Intervention: Drug: agomelatine
3 Completed A Study of Lu AA21004 in Comparison to Agomelatine in Adults Suffering From Major Depression Who Did Not Respond Well to Previous Medication
Condition: Major Depressive Disorder
Interventions: Drug: Lu AA21004;   Drug: agomelatine
4 Not yet recruiting Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder
Conditions: Major Depressive Disorder (MDD);   Coronary Heart Disease (CHD);   Cardiovascular Disease (CVD)
Interventions: Drug: Valdoxan (agomelatine);   Drug: Lexapro (escitalopram)
5 Recruiting Agomelatine Treatment of Depression in Schizophrenia (AGOPSYCH)
Conditions: Schizophrenia;   Schizophrenia-spectrum-disorders
Intervention: Drug: agomelatine
6 Terminated Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder
Intervention: Drug: AGO178
7 Completed Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Agomelatine (AGO178C);   Drug: Placebo
8 Unknown † Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder
Condition: Obsessive Compulsive Disorder
Interventions: Drug: Agomelatine A;   Drug: Placebo
9 Completed Pharmacokinetics of Agomelatine in Patients With Liver Impairment
Condition: Hepatic Impairment
Intervention: Drug: AGO178
10 Completed Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder
Interventions: Drug: Agomelatine (AGO178C);   Drug: Placebo
11 Completed Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: agomelatine;   Drug: placebo
12 Completed Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder (MDD)
Interventions: Drug: agomelatine;   Drug: placebo
13 Completed Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: agomelatine;   Drug: placebo
14 Completed Pharmacokinetics, Safety and Tolerability of AGO178C in Subjects With Renal Deficiencies Compared With Healthy Subjects
Condition: Renal Impairment
Intervention: Drug: AGO178C
15 Withdrawn The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: Agomelatine;   Drug: Fluoxentine
To Top

† Indicates status has not been verified in more than two years